Paraoxonase gene polymorphisms are associated with carotid arterial wall thickness in subjects with familial hypercholesterolemia

Atherosclerosis

Volumn 149, Issue 2, 2000, Pages 371-377

  Leus, Frank R ^a   Wittekoek, Marianne E ^b   Prins, Janke ^a   Kastelein, John J P ^b   Voorbij, Hieronymus A M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Atherosclerosis; Carotid arteries; Familial hypercholesterolemia; Intima media thickness; Paraoxonase genotype

Indexed keywords

ARYLDIALKYLPHOSPHATASE;

ADULT; AORTA WALL; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; ULTRASOUND;

ADULT; ARTERIOSCLEROSIS; ARYLDIALKYLPHOSPHATASE; BASE SEQUENCE; CAROTID ARTERIES; DNA; ESTERASES; FEMALE; GENOTYPE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; REFERENCE VALUES; REGRESSION ANALYSIS; RISK FACTORS; TUNICA INTIMA;

EID: 0034020289     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00324-X     Document Type: Article

References (41)

1. Goldstein J.L., Brown M.S. Familial hypercholesterolemia. Scriver C.R., Baudet A.L., Sly W.S., Valle D. The metabolic basis of inherited disease. 6th:1989;1215-1250 McGraw-Hill, New York.
2. Risk of fatal coronary heart disease in familial hypercholesterolemia. Br. Med. J. 303:1991;893-896.
3. Kotze M.J., De Villiers W.J., Steyn K., Kriek J.A., Marais A.D., Langenhoven E. et al. Phenotypic variation among familial hypercholesterolemics heterozygous for either one of two Afrikaner founder LDL receptor mutations. Arterioscler. Thromb. 13:1993;1460-1468.
4. Heiberg A., Slack J. Family similarities in the age at coronary death in familial hypercholesterolaemia. Br. Med. J. 2:1977;493-495.
5. Thompson G.R., Seed M., Nihthyananthan S., McCarthy S., Thorogood M. Genotypic and phenotypic variation in familial hypercholesterolemia. Arteriosclerosis. 9:1989;75-80.
6. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320:1989;915-924.
7. Witztum J.L., Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88:1991;1785-1792.
8. Mackness M.I., Arrol S., Durrington P.N. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett. 286:1991;152-154.
9. Watson A.D., Berliner J.A., Hama S.Y., La Du B.N., Faull K.F., Fogelman A.M. et al. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J. Clin. Invest. 96:1995;2882-2891.
10. Aviram M., Billecke S., Sorenson R., Bisgaier C., Newton R., Rosenblat M. et al. Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R. Arterioscler. Thromb. Vasc. Biol. 18:1998;1617-1624.
11. Cao H., Girard-Globa A., Berthezene F., Moulin P. Paraoxonase protection of LDL against peroxidation is independent of its esterase activity towards paraoxon and is unaffected by the Q→R genetic polymorphism. J. Lipid Res. 40:1999;133-139.
12. Mackness B., Mackness M.I., Arrol S., Turkie W., Durrington P.N. Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification. FEBS Lett. 423:1998;57-60.
13. Mackness M.I., Mackness B., Durrington P.N., Connelly P.W., Hegele R.A. Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins. Curr. Opin. Lipidol. 7:1996;69-76.
14. Mackness M.I., Durrington P.N. HDL, its enzymes and its potential to influence lipid peroxidation. Atherosclerosis. 115:1995;243-253.
15. Primo Parmo S.L., Sorenson R.C., Teiber J., La Du B.N. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics. 33:1996;498-507.
16. Humbert R., Adler D.A., Disteche C.M., Hassett C., Omiecinski C.J., Furlong C.E. The molecular basis of the human serum paraoxonase activity polymorphism. Nat. Genet. 3:1993;73-76.
17. Blatter Garin M.C., James R.W., Dussoix P., Blanche H., Passa P., Froguel P. et al. Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J. Clin. Invest. 99:1997;62-66.
18. Sanghera D.K., Aston C.E., Saha N., Kamboh M.I. DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease. Am. J. Hum. Genet. 62:1998;36-44.
19. Ruiz J., Blanche H., James R.W., Garin M.C., Vaisse C., Charpentier G. et al. Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet. 346:1995;869-872.
20. Zama T., Murata M., Matsubara Y., Kawano K., Aoki N., Yoshino H. et al. A 192Arg variant of the human paraoxonase (HUMPONA) gene polymorphism is associated with an increased risk for coronary artery disease in the Japanese. Arterioscler. Thromb. Vasc. Biol. 17:1997;3565-3569.
21. Herrmann S.M., Blanc H., Poirier O., Arveiler D., Luc G., Evans A. et al. The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM Study. Atherosclerosis. 126:1996;299-303.
22. Antikainen M., Murtomaki S., Syvanne M., Pahlman R., Tahvanainen E., Jauhiainen M. et al. The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns. J. Clin. Invest. 98:1996;883-885.
23. Ko Y.L., Ko Y.S., Wang S.M., Hsu L.A., Chang C.J., Chu P.H. et al. The Gln-Arg 191 polymorphism of the human paraoxonase gene is not associated with the risk of coronary artery disease among Chinese in Taiwan. Atherosclerosis. 141:1998;259-264.
24. Ombres D., Pannitteri G., Montali A., Candeloro A., Seccareccia F., Campagna F. et al. The Gln-Arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in Italian patients. Arterioscler. Thromb. Vasc. Biol. 18:1998;1611-1616.
25. Geroulakos G., O'Gorman D.J., Kalodiki E., Sheridan D.J., Nicolaides A.N. The carotid intima-media thickness as a marker of the presence of severe symptomatic coronary artery disease. Eur. Heart. J. 15:1994;781-785.
26. de Groot M.R., Banga J.D. Non-invasive ultrasound measurement of intima-media thickness. A tool to measure early atherosclerosis. Eur. J. Vasc. Surg. 8:1994;257-263.
27. Bonithon-Kopp C., Touboul P.J., Berr C., Leroux C., Mainard F., Courbon D. et al. Relation of intima-media thickness to atherosclerotic plaques in carotid arteries. The Vascular Aging (EVA) Study. Arterioscler. Thromb. Vasc. Biol. 16:1996;310-316.
28. Hodis H.N., Mack W.J., LaBree L., Selzer R.H., Liu C.R., Liu C.H. et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann. Intern. Med. 128:1998;262-269.
29. Wofford J.L., Kahl F.R., Howard G.R., McKinney W.M., Toole J.F., Crouse J.R.3. Relation of extent of extracranial carotid artery atherosclerosis as measured by B-mode ultrasound to the extent of coronary atherosclerosis. Arterioscler. Thromb. 11:1991;1786-1794.
30. O'Leary D.H., Polak J.F., Kronmal R.A., Manolio T.A., Burke G.L., Wolfson S.K.J. Jr Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N. Engl. J. Med. 340:1999;14-22.
31. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18:1972;499-502.
32. Thompson E.A., Deeb S., Walker D., Motulsky A.G. The detection of linkage disequilibrium between closely linked markers. Am. J. Hum. Genet. 42:1988;113-124.
33. Cao H., Girard-Globa A., Serusclat A., Bernard S., Bondon P., Picard S. et al. Lack of association between carotid intima-media thickness and paraoxonase gene polymorphism in non-insulin dependent diabetes mellitus. Atherosclerosis. 138:1998;361-366.
34. Sakai T., Matsuura B., Onji M. Serum paraoxonase activity and genotype distribution in Japanese patients with diabetes mellitus. Intern. Med. 37:1998;581-584.
35. Schmidt H., Schmidt R., Niederkorn K., Gradert A., Schumacher M., Watzinger N. et al. Paraoxonase PON1 polymorphism leu-Met54 is associated with carotid atherosclerosis: results of the Austrian stroke prevention study. Stroke. 29:1998;2043-2048. (in process citation).
36. Zannad F., Visvikis S., Gueguen R., Sass C., Chapet O., Herbeth B. et al. Genetics strongly determines the wall thickness of the left and right carotid arteries. Hum. Genet. 103:1998;183-188.
37. Kogawa K., Nishizawa Y., Hosoi M., Kawagishi T., Maekawa K., Shoji T. et al. Effect of polymorphism of apolipoprotein E and angiotensin-converting enzyme genes on arterial wall thickness. Diabetes. 46:1997;682-687.
38. Sass C., Zannad F., Herbeth B., Salah D., Chapet O., Siest G. et al. Apolipoprotein E4, lipoprotein lipase C447 and angiotensin-I converting enzyme deletion alleles were not associated with increased wall thickness of carotid and femoral arteries in healthy subjects from the Stanislas cohort. Atherosclerosis. 140:1998;89-95.
39. Hosoi M., Nishizawa Y., Kogawa K., Kawagishi T., Konishi T., Maekawa K. et al. Angiotensin-converting enzyme gene polymorphism is associated with carotid arterial wall thickness in non-insulin-dependent diabetic patients. Circulation. 94:1996;704-707.
40. Mackness M.I., Harty D., Bhatnagar D., Winocour P.H., Arrol S., Ishola M. et al. Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus. Atherosclerosis. 86:1991;193-199.
41. Mackness B., Mackness M.I., Arrol S., Turkie W., Julier K., Abuasha B. et al. Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus. Atherosclerosis. 139:1998;341-349.